Risk of seizure recurrence following a first unprovoked seizure in childhood: a prospective study. 1990

S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467.

In a prospective study, 283 children who presented with a first unprovoked seizure were followed for a mean of 30 months from the time of first seizure. Subsequent seizures were experienced by 101 children (36%). The cumulative risk of seizure recurrence for the entire study group was 26% at 12 months, 36% at 24 months, 40% at 36 months, and 42% at 48 months. The cumulative risk of recurrence in the 47 children with a remote symptomatic first seizure was 37%, 53%, and 60% at 12, 24, and 36 months, respectively, compared with a cumulative risk of 24%, 33%, and 36% at 12, 24, and 36 months, respectively, in the 236 children who had had an idiopathic first seizure (P less than .01). In children with an idiopathic first seizure, the electroencephalogram was the most important predictor of recurrence. The cumulative risk of recurrence in the 81 children with abnormal electroencephalograms was 41%, 54%, and 56% at 12, 24 and 36 months, respectively, but only 15%, 23%, and 26% at 12, 24, and 36 months, respectively, in the 138 children with normal electroencephalograms (P less than .001). A history of epilepsy in a first-degree relative was a significant risk factor only in idiopathic cases with abnormal electroencephalograms. In children with a remote symptomatic first seizure, either a history of prior febrile seizures or the occurrence of a partial seizure were significant predictors of recurrence. Age at first seizure and duration of seizure did not affect recurrence risk in either the idiopathic or remote symptomatic group. A total of 84% of the children were not treated with antiepileptic drugs or were treated for less than 2 weeks. Only 9% were treated for longer than 3 months. Treatment did not affect the risk of recurrence. The results suggest that, even without treatment, the majority of children with a first unprovoked seizure will not experiment a recurrence. Children with an idiopathic first seizure and a normal electroencephalogram have a particularly favorable prognosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D009519 New York City City located at the mouth of the Hudson River, in New York State.
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
January 2013, Journal of pediatric neurosciences,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
August 2000, Epilepsia,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
January 2009, Developmental medicine and child neurology,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
November 2015, No to hattatsu = Brain and development,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
September 2021, Brain & development,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
December 2003, Journal of tropical pediatrics,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
March 2004, Seizure,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
January 2008, Epilepsia,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
January 2024, Drug and therapeutics bulletin,
S Shinnar, and A T Berg, and S L Moshé, and M Petix, and J Maytal, and H Kang, and E S Goldensohn, and W A Hauser
August 2016, Seizure,
Copied contents to your clipboard!